Common Viruses May Be Triggering Alzheimer’s Disease

Varicella Zoster Virus, Herpes Simplex Virus and Alzheimer’s Disease

Varicella zoster virus (VZV), which commonly causes chickenpox and shingles, activates herpes simplex virus (HSV) from dormancy in neural tissue grown in vitro, which then leads to an increase in plaque deposits and decrease in neural signaling — hallmarks of Alzheimer’s disease. Credit: Tufts University

Shingles infection may awaken dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain.

Alzheimer’s disease is the most common cause of dementia in older adults and the 7th leading cause of death in the United States, according to the National Institute on Aging. It is a debilitating progressive illness that slowly destroys cognitive function and memory.

It can begin almost imperceptibly, often masquerading in the early months or years as forgetfulness that is very common in older age. What causes Alzheimer’s disease remains largely a mystery.

But researchers using a three-dimensional human tissue culture model mimicking the brain, have shown that varicella zoster virus (VZV), which commonly causes chickenpox and shingles, may activate herpes simplex (HSV), another common virus, to set in motion the early stages of Alzheimer’s disease. The study was conducted by scientists at Tufts University and the University of Oxford.

Normally HSV-1 – one of the main variants of the herpes simplex virus — lies dormant within the neurons of the brain. However, when it is activated it leads to the accumulation of tau and amyloid beta proteins and loss of neuronal function. These are signature elements found in patients with Alzheimer’s disease.

“Our results suggest one pathway to Alzheimer’s disease, caused by a VZV infection which creates inflammatory triggers that awaken HSV in the brain,” said Dana Cairns, GBS12, a research associate in the Tufts University Biomedical Engineering Department. “While we demonstrated a link between VZV and HSV-1 activation, it’s possible that other inflammatory events in the brain could also awaken HSV-1 and lead to Alzheimer’s disease.”

The study was published recently in the Journal of Alzheimer’s Disease.

Viruses Lying in Wait

“We have been working off a lot of established evidence that HSV has been linked to increased risk of Alzheimer’s disease in patients,” said David Kaplan, Stern Family Professor of Engineering and chair of the Department of Biomedical Engineering at Tufts’ School of Engineering. One of the first to hypothesize a connection between herpes virus and Alzheimer’s disease is Ruth Itzhaki of the University of Oxford, who collaborated with the Kaplan lab on this study.

“We know there is a correlation between HSV-1 and Alzheimer’s disease, and some suggested involvement of VZV, but what we didn’t know is the sequence of events that the viruses create to set the disease in motion,” he said. “We think we now have evidence of those events.”

According to the World Health Organization (WHO), an estimated 3.7 billion people under the age of 50 have been infected with HSV-1—the virus that causes oral herpes. In most cases it is asymptomatic, lying dormant within nerve cells.

When activated, it can cause inflammation in nerves and skin, causing painful open sores and blisters. Most carriers—and according to the CDC that’s one in two Americans—will have between very mild to no symptoms before the virus becomes dormant.

Varicella zoster virus is also extremely common, with about 95 percent of people having been infected before the age of 20. Many of those cases are expressed as chicken pox. VZV, which is a form of herpes virus, can also remain in the body, finding its way to nerve cells before becoming dormant.

Later in life, VZV can be reactivated to cause shingles. This disease is characterized by blisters and nodules in the skin that form in a band-like pattern and can be very painful, lasting for weeks or even months. One in three people will eventually develop a case of shingles in their lifetime.

The link between HSV-1 and Alzheimer’s disease only occurs when HSV-1 has been reactivated to cause sores, blisters, and other painful inflammatory conditions.

How Sleeping Viruses May Wake

To better understand the cause-and-effect relationship between the viruses and Alzheimer’s disease, the Tufts scientists re-created brain-like environments in small 6-millimeter-wide donut-shaped sponges made of silk protein and collagen.

They populated the sponges with neural stem cells that grow and become functional neurons capable of passing signals to each other in a network, just as they do in the brain. Some of the stem cells also form glial cells, which are typically found in the brain and help keep the neurons alive and functioning.

The researchers found that neurons grown in the brain tissue can be infected with VZV, but that alone did not lead to the formation of the signature Alzheimer’s proteins tau and beta-amyloid—the components of the tangled mess of fibers and plaques that form in Alzheimer’s patients’ brains—and that the neurons continued to function normally.

However, if the neurons already harbored quiescent HSV-1, the exposure to VZV led to a reactivation of HSV, and a dramatic increase in tau and beta-amyloid proteins, and the neuronal signals begin to slow down.

“It’s a one-two punch of two viruses that are very common and usually harmless, but the lab studies suggest that if a new exposure to VZV wakes up dormant HSV-1, they could cause trouble,” said Cairns.

“It’s still possible that other infections and other pathways of cause and effect could lead to Alzheimer’s disease, and risk factors such as head trauma, obesity, or alcohol consumption suggest they may intersect at the re-emergence of HSV in the brain,” she added.

The scientists observed that the VZV infected samples started to produce a higher level of cytokines—proteins that are often involved in triggering an inflammatory response. Kaplan noted that VZV is known in many clinical cases to cause inflammation in the brain, which could possibly lead to activation of dormant HSV and increased inflammation.

Repeat cycles of HSV-1 activation can lead to more inflammation in the brain, production of plaques, and accumulation of neuronal and cognitive damage.

A vaccine for VZV—to prevent chickenpox and shingles—has also been shown to considerably reduce the risk of dementia. It’s possible that the vaccine is helping to stop the cycle of viral reactivation, inflammation, and neuronal damage.

Also noted by the research are the long-term neurological effects that some COVID-19 patients have experienced from the SARS-CoV-2 virus, particularly among the elderly, and that both VZV and HSV-1 can be reactivated after a COVID infection. Keeping an eye on possible follow-on cognitive effects and neurodegeneration would be advisable in these cases, they said.

Reference: “Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1” by  Dana M. Cairns, Ruth F. Itzhaki and David L. Kaplan, 20 June 2022, Journal of Alzheimer s Disease.
DOI: 10.3233/JAD-220287

Funding: NIH/National Institutes of Health

5 Comments on "Common Viruses May Be Triggering Alzheimer’s Disease"

  1. Alzheimers is going to be like Cancer. It’s the I dunno doesn’t run in my family. A friend’s response when told he has kidney cancer. However unlike everyone else he smokes. 66 been doing it since 17.

  2. So basically if we stop eating and stop having sex we can avoid most illness?

  3. According to Dr. Richard Fleming, Covid 19 has prion-like-domain on the spikes of the spike protein. These “prion-like-domains” can cause spongiform encephalopathies in the brain. And these encephalopathies are found in Alzheimer’s, Parkinson’s, and the human form of “Mad Cow” disease. Dr. Fleming has so much information on his website. Over 200 different sources of documentation as well. He also predicts that any past immunizations that people have had before Covid, may not protect against the dieases they were immunized for. (Notice all the shingles ads on TV?)…..It’s worth looking at his website, if you are looking for truth on all things Covid, and mRNA vaccines.

  4. Ilya B. Tsyrlov, M.D., Ph.D. | August 6, 2022 at 3:17 pm | Reply

    While a distinct mechanistic pathway of how Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1 was not shown, we’ve demonstrated that body burden dioxins (even concentrations of those in human brain) might play a decisive role in pathogenesis of Alzheimer Disease by trans-activation of HSV-1 in glial cells. Ref.: Tsyrlov, I.B., Shur, I.N., Appelbaum, J., Wu, J. (June 2017). “AhR-ARNT signaling pathway mediates transcriptional activation of HSV-1 in glial cells: a pathogenic factor that might affect AD development”. Alzheimer’s and Dementia. 13(7):P1438-P1439. DOI: 10.1016/j.jalz.2017.06.2252. Tsyrlov, I.B., Wu, J., Shur, I.N., Oshchepkov, D.Yu. (July 2016), “Alzheimer’s disease causative viruses HSV-1 and CMV are highly susceptible targets for bHLH/PAS dioxin receptor-Arnt transcription pathway in glial cells”. Alzheimer’s and Dementia. 12(7):P632-633. DOI:10.1016/j.jalz.2017.06.2252

    Brief Sinopsis.
    It has been indicated in 100+ publications by many groups that the neurotropic HSV-1 might be a causative element of Alzheimer’s disease and mental retardation in elderlies. No distinct factor responsible for reactivation of HSV-1 is revealed yet. While this dormant herpes virus lytic cycle activation in the brain typically linked to stress, immunosuppression, or inflammation, the extremely potent chemical factor in human body has been overlooked, namely TCDD, traces of which exist in human brain tissue. To address the point, Tsyrlov created the Project dedicated to Alzheimer’s disease. It is based on reactivation of dormant human viruses by traces of TCDD, the most potent xenobiotic so far know. TCDD is shown to bioaccumulate progressively during maturation and aging) in human tissues, and its estimated half-life in humans is about 10 yr. This is the worst-case scenario of chemico-biological interactions, which supposes that “dormant human xenobiotic” TCDD is able to trans-activate the HSV-1 gene via host cell bHLH/PAS transcriptional complex. Presumably, binding of the activated complex at the viral promoter harboring DRE might occur while the HSV-1 progeny is formed in the nucleus of the infected cell, and viral DNA is packed into preformed capsids. TCDD at 1.0-5.0 pM was shown to cause a multifold elevation of HSV-1 titer and viral DNA content in HSV-1 infected murine Apoe(-/-) astrocytes and human astrocytoma U-87MG cells.

    So, reactivation of HSV-1 was demonstrated with TCDD concentrations close to the current dioxin body burden level in the general population. The astrocytoma cell lines were chosen because earlier amyloid plaques and their development during Alzheimer’s disease intimately linked to activated astrocytes. Epidemiological outlook has noticed the relationship of a higher rate of Alzheimer’s disease among native Arctic populations, and elevated dioxin body burden due to regular consumption of sea mammal fat contaminated with TCDD and DLC. So, multiple promoter DREs in HSV-1 and a remarkable sensitivity of HSV-1 in target brain cells to single picomolar concentrations of TCDD, all make this dormant neurotropic virus to become the target for TCDD in brain tissues. Supposedly, in each and every case the real chance of latent HSV-1 reactivation by TCDD in brain cells is determined by the AhR affinity to TCDD, which varied ~15-fold in human populations.

  5. No Eric, stopping eating is sufficient.

Leave a comment

Email address is optional. If provided, your email will not be published or shared.